等待开盘 02-07 09:30:00 美东时间
+0.150
+7.17%
NuCana plc (NASDAQ: NCNA) ("NuCana" or the "Company"), a clinical-stage biopharmaceutical company focused on improving treatment outcomes for patients with cancer, announced the appointment of Theresa Bruce as Chief
01-06 21:01
Shares of Telesis Bio, Inc. (NASDAQ:TBIO) rose sharply in today's pre-market tr...
2024-09-26 18:31
NuCana plc (NASDAQ:NCNA) announced the issuance of a new patent by the United States Patent and Trademark Office (USPTO) covering NUC-7738's composition of matter. This patent (US12,054,510) is expected to serve as a key
2024-09-26 04:03
U.S. stocks traded mixed midway through trading, with the Nasdaq Composite fall...
2024-09-17 00:31
NCNA: 282% | NuCana Presented Final Data From Phase 2 Nutide:701 Study At ESMO Congress On NUC-7738 In Combination With Pembrolizumab For Patients With Metastatic Melanoma Who Were Refractory To Or Had Relapsed On
2024-09-16 20:08
Shares of Exicure, Inc. (NASDAQ:XCUR) rose sharply in today's pre-market tradin...
2024-09-16 18:07
Gainers Theriva Biologics (AMEX:TOVX) shares moved upwards by 34.2% to $6.31 during Monday's pre-market session. The market value of their outstanding shares is at $6.3 million. Emergent BioSolutions (NYSE:EBS) shares rose 17.62% to $10.48. The market value of their outstanding shares is at $549.1 m...
2024-09-02 20:05
11:10 AM EDT, 08/30/2024 (MT Newswires) -- European equities traded in the US as American depositary receipts edged lower late Friday morning, nudging down 0.03% to 1,476.31 on the S&P Europe Select ADR Index. From continental Europe, the gainers were led by medical device maker EDAP TMS (EDAP) and ...
2024-08-30 23:10
William Blair analyst Matthew Phipps downgrades NuCana (NASDAQ:NCNA) from Outperform to Market Perform.
2024-08-30 21:28